Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial (Q47247699)

12 January 2018

title

Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial (English)

1 reference

12 January 2018

author name string

Fijal BA

series ordinal

1

1 reference

12 January 2018

Hall JM

series ordinal

2

1 reference

12 January 2018

Witte JS

series ordinal

3

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

12 January 2018

Contemporary Clinical Trials

published in

1 reference

12 January 2018

volume

21

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

page(s)

7-20

1 reference

12 January 2018

Genes, disease and medicine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

The study of candidate genes in drug trials: sample size considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

In search of AIDS-resistance genes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Comparative genetics of resistance to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

To screen or not to screen: how to improve clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Reducing patient eligibility criteria in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

High risk subjects and the cost of large field trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Validity versus generalizability in clinical trial design and conduct.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

NIH institute to work with trial of AIDS vaccine, despite concerns

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900039-2

7 January 2021

10.1016/S0197-2456(99)00039-2

Identifiers

DOI

1 reference

12 January 2018

release_xzmnbhwg6vc37nj2yojwnygsja

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xzmnbhwg6vc37nj2yojwnygsja

24 November 2022

mapped directly with Wikidata item

1 reference

12 January 2018